Cell Reports
(Oct 2014)
Antivirulence Properties of an Antifreeze Protein
Martin Heisig,
Nabil M. Abraham,
Lei Liu,
Girish Neelakanta,
Sarah Mattessich,
Hameeda Sultana,
Zhengling Shang,
Juliana M. Ansari,
Charlotte Killiam,
Wendy Walker,
Lynn Cooley,
Richard A. Flavell,
Herve Agaisse,
Erol Fikrig
Affiliations
Martin Heisig
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Nabil M. Abraham
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Lei Liu
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Girish Neelakanta
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Sarah Mattessich
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Hameeda Sultana
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Zhengling Shang
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Juliana M. Ansari
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Charlotte Killiam
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Wendy Walker
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
Lynn Cooley
Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA
Richard A. Flavell
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
Herve Agaisse
Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA
Erol Fikrig
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
DOI
https://doi.org/10.1016/j.celrep.2014.09.034
Journal volume & issue
Vol. 9,
no. 2
pp.
417
– 424
Abstract
Read online
As microbial drug-resistance increases, there is a critical need for new classes of compounds to combat infectious diseases. The Ixodes scapularis tick antifreeze glycoprotein, IAFGP, functions as an antivirulence agent against diverse bacteria, including methicillin-resistant Staphylococcus aureus. Recombinant IAFGP and a peptide, P1, derived from this protein bind to microbes and alter biofilm formation. Transgenic iafgp-expressing flies and mice challenged with bacteria, as well as wild-type animals administered P1, were resistant to infection, septic shock, or biofilm development on implanted catheter tubing. These data show that an antifreeze protein facilitates host control of bacterial infections and suggest therapeutic strategies for countering pathogens.
WeChat QR code
Close